企業プロフィール
Synaptogenix 株価・ニュース・カタリスト
- ティッカー:
- SNPX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
24.55 USD (+1.20%)
終値
最終更新: 2026年4月20日
—
時価総額
株価変動の要因
Current closing-price context is not available for SNPX.
企業概要
事業概要
Synaptogenix is a biotechnology company focused on neurodegenerative disease and synaptic biology. Its story centers on trying to translate brain-health science into therapies for difficult neurologic conditions.
所在地とセクター分類
Synaptogenix is headquartered in the United States and listed on NASDAQ. It sits in small-cap neuroscience biotechnology.
ビジネスモデルの特徴
The company depends on clinical and translational progress, capital efficiency, and the ability to maintain a focused neurologic thesis. Investors usually watch early data and strategic direction.
バイオ業界での位置付け
Synaptogenix occupies a small neuroscience niche within biotech. It remains catalyst-sensitive because the company still needs to prove its platform in a difficult disease area.
今後のカタリスト
- Synaptogenix is a legacy / closeout story now, with catalysts limited to any strategic update. The market is not treating it like an active growth story.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。